ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 141 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $743,279 | -46.4% | 758,448 | -24.0% | 0.00% | – |
| Q2 2023 | $1,387,324 | -21.1% | 998,075 | -9.8% | 0.00% | – |
| Q1 2023 | $1,758,987 | -87.1% | 1,106,281 | -49.5% | 0.00% | -100.0% |
| Q4 2022 | $13,637,445 | +160.5% | 2,188,996 | +180.1% | 0.00% | +200.0% |
| Q3 2022 | $5,235,000 | +176.7% | 781,538 | +162.7% | 0.00% | – |
| Q2 2022 | $1,892,000 | +116.5% | 297,494 | +57.7% | 0.00% | – |
| Q1 2022 | $874,000 | -62.9% | 188,618 | -60.0% | 0.00% | – |
| Q4 2021 | $2,357,000 | -66.3% | 471,417 | -18.8% | 0.00% | -100.0% |
| Q3 2021 | $7,000,000 | -30.0% | 580,867 | +22.9% | 0.00% | -50.0% |
| Q2 2021 | $9,996,000 | +82.5% | 472,613 | +142.0% | 0.00% | +100.0% |
| Q1 2021 | $5,478,000 | -43.9% | 195,314 | -48.0% | 0.00% | -50.0% |
| Q4 2020 | $9,767,000 | +64.1% | 375,674 | +134.6% | 0.00% | +100.0% |
| Q3 2020 | $5,953,000 | -42.8% | 160,167 | -21.1% | 0.00% | -75.0% |
| Q2 2020 | $10,413,000 | +16.8% | 202,938 | -28.2% | 0.00% | -20.0% |
| Q1 2020 | $8,916,000 | -51.0% | 282,767 | -7.3% | 0.01% | -37.5% |
| Q4 2019 | $18,195,000 | +28.4% | 305,125 | -21.1% | 0.01% | +14.3% |
| Q3 2019 | $14,171,000 | -5.6% | 386,564 | +19.7% | 0.01% | 0.0% |
| Q2 2019 | $15,019,000 | +55.2% | 322,863 | +33.9% | 0.01% | +40.0% |
| Q1 2019 | $9,680,000 | +13.2% | 241,116 | +29.7% | 0.01% | 0.0% |
| Q4 2018 | $8,548,000 | +2.6% | 185,845 | -1.1% | 0.01% | +66.7% |
| Q3 2018 | $8,334,000 | +22.8% | 187,830 | +8.5% | 0.00% | 0.0% |
| Q2 2018 | $6,786,000 | -88.7% | 173,143 | -79.2% | 0.00% | -90.9% |
| Q1 2018 | $60,282,000 | +85.6% | 833,427 | +68.9% | 0.03% | +73.7% |
| Q4 2017 | $32,485,000 | +617.4% | 493,392 | +446.2% | 0.02% | +533.3% |
| Q3 2017 | $4,528,000 | +109.5% | 90,332 | +93.4% | 0.00% | +50.0% |
| Q2 2017 | $2,161,000 | -33.1% | 46,700 | -49.0% | 0.00% | -33.3% |
| Q1 2017 | $3,231,000 | +2484.8% | 91,500 | +815.0% | 0.00% | – |
| Q4 2016 | $125,000 | -83.3% | 10,000 | -81.5% | 0.00% | – |
| Q3 2016 | $749,000 | +323.2% | 54,095 | +201.3% | 0.00% | – |
| Q2 2016 | $177,000 | -56.3% | 17,952 | -25.0% | 0.00% | -100.0% |
| Q1 2016 | $405,000 | +161.3% | 23,930 | +244.4% | 0.00% | – |
| Q4 2015 | $155,000 | -96.2% | 6,949 | -96.0% | 0.00% | -100.0% |
| Q3 2015 | $4,083,000 | +80.3% | 173,114 | +524.8% | 0.00% | +100.0% |
| Q2 2015 | $2,265,000 | -78.3% | 27,706 | -75.5% | 0.00% | -80.0% |
| Q1 2015 | $10,458,000 | – | 112,937 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 2,679,835 | $69,675,000 | 19.39% |
| Endurant Capital Management LP | 207,293 | $5,390,000 | 1.94% |
| Bellevue Group AG | 5,138,451 | $133,599,000 | 1.53% |
| Rhenman & Partners Asset Management AB | 592,225 | $15,398,000 | 1.26% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,562,869 | $40,635,000 | 0.93% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 31,434 | $817,000 | 0.62% |
| WASATCH ADVISORS LP | 3,998,010 | $103,949,000 | 0.51% |
| HAMILTON LANE ADVISORS LLC | 46,181 | $1,201,000 | 0.45% |
| Boxer Capital, LLC | 500,000 | $13,000,000 | 0.42% |
| DCF Advisers, LLC | 38,500 | $1,001,000 | 0.41% |